Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Non-Current Debt (2024)

Universe Pharmaceuticals' Non-Current Debt history spans 1 years, with the latest figure at $2.1 billion for Q3 2024.

  • For Q3 2024, Non-Current Debt changed N/A year-over-year to $2.1 billion; the TTM value through Sep 2024 reached $2.1 billion, changed N/A, while the annual FY2024 figure was $2.1 billion, N/A changed from the prior year.
  • Non-Current Debt for Q3 2024 was $2.1 billion at Universe Pharmaceuticals.
  • Across five years, Non-Current Debt topped out at $2.1 billion in Q3 2024 and bottomed at $2.1 billion in Q3 2024.